Grifols, Brookfield Asset Management

Grifols to Outline Standalone Strategy After Brookfield Drops $6.8 Billion Bid
Grifols said it plans to outline its strategy as a standalone company after Brookfield Asset Management dropped out of talks for a 6.45 billion-euro ($6.82 billion) takeover bid.The Spanish pharmaceutical company said late Wednesday that it would soon schedule an investor update at which it would present its strategy under new leadership and its plans to unlock growth opportunities.
Brookfield Drops $6.8 Billion Offer to Buy Drugmaker Grifols
Brookfield Asset Management Ltd. walked away from a plan to acquire Grifols SA, ending months of negotiations to take over the Spanish blood-plasma company.
Grifols slides as Brookfield pulls out of takeover talks
Barcelona-based Grifols has seen its stock value plummet since January when short seller Gotham City Research accused the company of manipulating debt and earnings reporting by consolidating profit from businesses that were sold to a 'vehicle' owned by its founding family.
Grifols shares tumble after Brookfield drops takeover plan
Canadian fund Brookfield said on Wednesday it has dropped its plan to take over Spain's Grifols due to a disagreement over the pharmaceutical company's value.
Brookfield Set to Drop Grifols Bid as Family Shuns Others
Brookfield Asset Management Ltd. is preparing to walk away from a plan to acquire Grifols SA over disagreements on valuation. The Spanish company’s billionaire founding family said it won’t support any new bid to take its namesake drug-maker private.
Grifols shares sink after Brookfield walks away from €6.45bn offer
Brookfield Asset Management has walked away from an acquisition of Spanish healthcare group Grifols after months of negotiations, sending shares in the short seller target down almost 13 per cent.
Brookfield abandons plan for €6.45-billion takeover of drug maker Grifols
Brookfield withdrew its bid for the Spanish pharmaceutical company following a deadlock between the two side over price
Grifols ADRs Tumble After Brookfield Reportedly Backs Away from Takeover Bid
Grifols' American depositary receipts slumped following a report that Brookfield Asset Management plans to abandon its acquisition of the Spanish pharmaceuticals company. The stock was down 18% at $7.14 in premarket trading. Shares had already fallen nearly 25% year-to-date when the market closed Tuesday.
Grifols shares tumble after report on Brookfield abandoning takeover plan
Shares in Grifols were falling on Wednesday morning after Bloomberg reported Canadian fund Brookfield is considering dropping its plan to take over the Spanish pharmaceutical firm. The Canadian private equity firm is walking away on disagreement on the company's value,
Brookfield Is Said to Plan to Walk Away From Grifols Bid
Brookfield Asset Management Ltd. is preparing to walk away from a plan to acquire Grifols SA over disagreements on valuation for the Spanish drug maker, according to people familiar with the matter.
Grifols drops as Brookfield is said to drop take-private bid
Grifols (GRFS) stock dropped as Brookfield Asset Management (BAM) is reportedly withdrawing its offer to take the plasma therapeutics company private. Read more here.
Billionaire Grifols Family’s Woes in Focus After Brookfield Exit
For Spain’s billionaire Grifols family, which turned a blood-collection business into one of the world’s largest medical ...
Grifols Board Announces Termination Of Discussions With Brookfield - Quick Facts
The Board of Directors of Grifols (GRFS) announced the termination of discussions with Brookfield Capital Partners UK regarding a ...
Brookfield drops US$6.8-billion offer to buy drugmaker Grifols
Grifols shares fell as much as 14 per cent after the news was published by Bloomberg, the biggest intra-day decline since Feb ...
Brookfield abandona oferta de US$6.800 millones por farmacéutica Grifols
Brookfield Asset Management Ltd. abandonó los planes de adquirir Grifols SA, poniendo fin a meses de negociaciones para ...